Oslo, Norway, April 26, 2024.
The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2023. Please find the report attached, as well as the report according to the European Single Electronic Format (ESEF). The Annual Report 2023 is also available on the company’s website www.pcibiotech.com.
For further information, please contact:
PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo
Ronny Skuggedal, CEO, rs@pcibiotech.no, Mobile: +47 940 05 757
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Attachments
LUXEMBOURG, April 23, 2025 /PRNewswire/ -- Decentralized Biotechnology Intelligence Holding Group Inc. (dBio), a leading…
YORBA LINDA, Calif., April 23, 2025 /PRNewswire/ -- Labroots, the leading scientific social networking website…
NEW YORK--(BUSINESS WIRE)--Aleutian Capital Group (“Aleutian”) is pleased to announce Valsoft Corporation (“Valsoft”) successful acquisition…
Achievement is set to accelerate enterprise AI solutions through Microsoft's startup acceleration program LOUISVILLE, Ky.--(BUSINESS…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="1px" width="1px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
